Research output per year
Research output per year
Personal profile
Personal webpage
https://www.kuball-laboratories.com/jurgen-kuball
http://nl.linkedin.com/pub/jurgen-kuball/88/156/49b
Biography
Prof. Dr. Jürgen Kuball received his medical degree as hematologists at the University of Mainz, Germany, and was further trained at the Fred Hutchinson Cancer Center in Seattle, WA, USA. Prof. Kuball joined the Department of Hematology at the University Medical Center in Utrecht in The Netherlands in 2007 as hematologists and immunologist. He became a VIDI-laureate in 2010 and chairs the section applied & tumor-immunology within the laboratory of translation immunology. Since 2013 he is chairing the Department of Hematology (adults). His clinical activities are focusing on treating patients with hematological malignancies including stem cell transplantation. His clinical-translational efforts and patient care are driven by his role as Director of the Bone Marrow Transplantation Program at the University Medical Center Utrecht, as well as active membership of the leukemia working party and stem cell working party of HOVON. His current laboratory activities are focusing on the understanding of innate immune cells and their receptors to recognize malignant cells and virally infected cells as well as the genetic engineering of a transplant.
For more information on experimental and translational research please visit Kuball Laboratories
Side activities
Board activities
- Chair Immunology Community Utrecht Life Science 2023-
- Secretary-Team of GoCART Coalition 2023-
- EBMT Chair Legal and Regulatory Affairs Committee 2019-
- HOVON General board 2014-
- KWF PPS commissie 2022-
- KWF adviesraad 2016-2022
- Wetenschappelijke raad KIKA 2018-2021
Translational Valorisation
- Cofounder and shareholder of Gadeta 2015- 2023
- Patent holder on multipe inventions licensed to Gadeta-follow up company Century Therapeuitcs and Miltenyi Biotech 2012-
- Via Gadeta Founders since 2024 Shareholder of Century Therapeutics
- Receiving revenues from licensed patents in the field of genetic engineering 2021-
Memberships
- ASH
- EBMT
- EHA Member
- HOVON Leukemia working party
- HOVON SCT working party
External positions
- Scientific advisor, GADETA, 2018 → 2020
- Scientific Advisory Board, JAZZ pharmaceuticals, 11 Sep 2016
- Scientific cofounder and CSO, GADETA, 2015 → 2018
- Grant Support, speaker and joint patent application, Miltenyi Biotec, 2015 → …
- Grant and Scientific advisory board, Novartis, 2015 → …
Fellowship & awards
American Association of Cancer Research-GlaxoSmithKline Scholar in Cancer Research Award (2001)
Stipendiat der Deutschen Krebshilfe (2005-2007)
Team Science recognition award of the „Society for Immunotherapy of Cancer“ to Jürgen Kuball and the University of Washington, USA (2010)
VIDI-Laureate ZonMW, The Netherlands (2010)
External positions
aandeelhouder - shareholder via Gadeta Founders - Century Therapeutics & Adeta
1 Jan 2024 → 31 Dec 3999
Chair - Chairing - Immunology Community Life Science
1 Jan 2023 → 31 Dec 3999
Secretary team member - bestuurslid - GoCART Coalition (EBMT/EHA)
1 Jan 2023 → 31 Dec 3999
Inkomsten licentie - Onderzoek - UMCU Holding
1 Jan 2022 → 31 Dec 3999
Commissie lid PPS commissie - grant indieningen voor KWF beoordelen - KWF
1 Jan 2022 → 31 Dec 3999
aandeelhouder - Receiving revenues from licensed patents via UMCU - UMC Holding
1 Jan 2021 → 31 Dec 3999
Chair legal and rgulatory affairs committee - Chair - EBMT
1 Jan 2019 → 31 Dec 3999
grant - grant ontvangen voor onderzoek - Novartis
1 Jan 2015 → 31 Dec 3999
Onderzoeker - grant ontvangen voor onderzoek - Miltenyi
1 Jan 2015 → 31 Dec 3999
bestuurslid - member general Board - HOVON
1 Jan 2014 → 31 Dec 3999
Patent holder multipe inventions licensed to Gadeta-follow up company Century Therapeuitcs &Miltenyi - Patent houder - Various
1 Jan 2013 → 31 Dec 3999
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Nabergoj, M., Eikema, D-J., Koster, L., Platzbecker, U., Sockel, K., Finke, J., Kröger, N., Forcade, E., Nagler, A., Eder, M., Tischer, J., Broers, A. E. C., Kuball, J., Wilson, K. M. O., Hunault-Berger, M., Collin, M., Russo, D., Corral, L. L., Helbig, G., Mussetti, A., & 7 others, Mar 2024, In: Bone Marrow Transplantation. 59, 3, p. 395-402 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Allogeneic Hematopoietic Cell Transplantation for VEXAS Syndrome: Results of a Multicenter Study of the EBMT
Gurnari, C., Koster, L., Baaij, L. G. A., Heiblig, M., Yakoub-Agha, I., Collin, M., Passweg, J. R., Bulabois, C-E., Khan, A. B., Loschi, M., Carnevale-Schianca, F., Crisà, E., Caravelli, D., Kuball, J., Saraceni, F., Olivieri, A., Rambaldi, A., Kulasekararaj, A. G., Hayden, P., Badoglio, M., & 13 others, 26 Mar 2024, In: Blood Advances. 8, 6, p. 1444-1448 5 p.Research output: Contribution to journal › Letter › Academic › peer-review
Open AccessFile7 Downloads (Pure) -
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response
Alieva, M., Barrera Román, M., de Blank, S., Petcu, D., Zeeman, A. L., Dautzenberg, N. M. M., Cornel, A. M., van de Ven, C., Pieters, R., den Boer, M. L., Nierkens, S., Calkoen, F. G. J., Clevers, H., Kuball, J., Sebestyén, Z., Wehrens, E. J., Dekkers, J. F. & Rios, A. C., Jul 2024, In: Nature protocols. 19, 7, p. 2052-2084 33 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapies
Chabannon, C., Ruggeri, A., Montoto, S., van Biezen, A., van der Werf, S., Markslag, A., Sanchez-Ortega, I., Camara, R. D. L., Ljungman, P., Mohty, M., Kröger, N., Sureda, A., McGrath, E., Bonini, C. & Kuball, J., Jun 2024, In: Best Practice and Research: Clinical Haematology. 37, 2, 8 p., 101557.Research output: Contribution to journal › Review article › peer-review
Open AccessFile1 Downloads (Pure) -
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Lo Presti, V., Meringa, A., Dunnebach, E., van Velzen, A., Moreira, A. V., Stam, R. W., Kotecha, R. S., Krippner-Heidenreich, A., Heidenreich, O. T., Plantinga, M., Cornel, A., Sebestyen, Z., Kuball, J., van Til, N. P. & Nierkens, S., 5 Apr 2024, In: Journal for ImmunoTherapy of Cancer. 12, 4, 15 p., e008174.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile11 Downloads (Pure)
Activities
-
Antibody Engineering and Therapeutics Europe
Jeanette Leusen (Keynote/plenary speaker) & JHE Kuball (Invited speaker)
10 Jun 2020 → 11 Jun 2020Activity: Participating in or organising an event › Participation in conference › Academic
-
Bureaucratische regels en te weinig geld: Jaagt Nederland toponderzoek het land uit?
Hans Clevers (Interviewee), S.A. Fuchs (Interviewee), JHE Kuball (Interviewee) & A.L. Bredenoord (Interviewee)
9 Mar 2020Activity: Other › Types of Public engagement and outreach - Media article or participation